BioSpace News Archive

Drug Development

NeurAegis Announces Publication of Preclinical Animal Data Supporting Calpain-2 as a Promising Therapeutic Target for Status Epilepticus

NeurAegis, Inc., a neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders, today announced the publication of a paper titled “Calpain-2 Activation in Mouse Hippocampus Plays a Critical Role in Seizure-Induced Neuropathology” in the peer-reviewed journal Neurobiology of Disease.

February 18, 2021
·
2 min read
Business

Agadia Systems, Inc. Announces Agreement with Blue Cross and Blue Shield of Kansas City for use of Agadia’s Electronic Prior Authorization Solution, PAHub™

Agadia Systems, Inc. (Agadia), a recognized healthcare technology solution provider for Health Plans & PBMs is announcing an agreement with Blue Cross and Blue Shield of Kansas City (Blue KC), to utilize PAHub, Agadia’s HITRUST certified, end-to-end Electronic Prior Authorization management solution.

February 18, 2021
·
1 min read